Alain Dostie
pharmaceutical
Nanobiotix SA
France
Biography
Alain Dostie has been appointed as Chief Operating Officer of the Company. Mr. Dostie will lead Nanobiotix's operations, including development, manufacturing, market access and sales, for the Company's lead product NBTXR3, which could obtain a CE Mark approval in 2017. Previously, Mr. Dostie was the Oncology General Manager at Novartis Germany. He joins Nanobiotix with over 25 years of international experience in the pharmaceutical industry, particularly in market access and oncology.
Research Interest
Pharmaceutical Science
